BioPOA Co., Ltd. presented its achievements at the “Company Performance Sharing Demo Day” held on December 3.
During the event, BioPOA introduced its “PoaVac PRRS Live Vaccine,” developed using the world’s first reverse-genetics–based SAVE technology, as well as its GMP facilities.
Companies were evaluated comprehensively on their competitiveness, growth potential, and other key factors, and BioPOA Co., Ltd. was selected as an Excellence Award recipient.
(See article : [한국경제] 지금껏 1조 7000억원 투자 지원..."농식품 모태펀드 덕에 성장했다" )
BioPOA Co., Ltd. presented its achievements at the “Company Performance Sharing Demo Day” held on December 3.
During the event, BioPOA introduced its “PoaVac PRRS Live Vaccine,” developed using the world’s first reverse-genetics–based SAVE technology, as well as its GMP facilities.
Companies were evaluated comprehensively on their competitiveness, growth potential, and other key factors, and BioPOA Co., Ltd. was selected as an Excellence Award recipient.
(See article : [한국경제] 지금껏 1조 7000억원 투자 지원..."농식품 모태펀드 덕에 성장했다" )